TY - JOUR
T1 - Influence of a 3′ Terminal Ribozyme on AgoshRNA Biogenesis and Activity
AU - Herrera-Carrillo, Elena
AU - Gao, Zongliang
AU - Berkhout, Ben
PY - 2019
Y1 - 2019
N2 - Short hairpin RNAs (shRNAs)can induce gene silencing via the RNA interference (RNAi)mechanism. We designed an alternative shRNA molecule with a relatively short base-paired stem that bypasses Dicer and instead is processed by the Argonaute 2 (Ago2)protein into a single guide RNA strand that effectively induces RNAi. We called these molecules AgoshRNAs. Active anti-HIV AgoshRNAs were developed, but their RNAi activity was generally reduced compared with the matching shRNAs. In an attempt to further optimize the AgoshRNA design, we inserted several self-cleaving ribozymes at the 3′ terminus of the transcribed AgoshRNA and evaluated the impact on AgoshRNA processing and activity. The hepatitis delta virus (HDV)ribozyme is efficiently removed from the transcribed AgoshRNAs and generates a uniform 3′ overhang, which translates into the enhanced antiviral activity of these molecules.
AB - Short hairpin RNAs (shRNAs)can induce gene silencing via the RNA interference (RNAi)mechanism. We designed an alternative shRNA molecule with a relatively short base-paired stem that bypasses Dicer and instead is processed by the Argonaute 2 (Ago2)protein into a single guide RNA strand that effectively induces RNAi. We called these molecules AgoshRNAs. Active anti-HIV AgoshRNAs were developed, but their RNAi activity was generally reduced compared with the matching shRNAs. In an attempt to further optimize the AgoshRNA design, we inserted several self-cleaving ribozymes at the 3′ terminus of the transcribed AgoshRNA and evaluated the impact on AgoshRNA processing and activity. The hepatitis delta virus (HDV)ribozyme is efficiently removed from the transcribed AgoshRNAs and generates a uniform 3′ overhang, which translates into the enhanced antiviral activity of these molecules.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064748353&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31048184
U2 - https://doi.org/10.1016/j.omtn.2019.04.001
DO - https://doi.org/10.1016/j.omtn.2019.04.001
M3 - Article
C2 - 31048184
SN - 2162-2531
VL - 16
SP - 452
EP - 462
JO - Molecular Therapy. Nucleic Acids
JF - Molecular Therapy. Nucleic Acids
ER -